EPNextS Launches 'FamiKone' to Promote Dementia Awareness and Prevention in Families

EPNextS Launches 'FamiKone'

On September 18, 2025, EPNextS, a Japan-based healthcare solutions provider, officially initiated an innovative program called 'Family Learning about Dementia' or 'FamiKone.' This initiative is designed to raise awareness and educate families about dementia prevention, especially for those with senior family members.

Through engaging and easy-to-understand information delivered via YouTube and LINE, 'FamiKone' aims to empower families to be prepared for any situation regarding their loved ones' health.

Key Features of 'FamiKone'

'FamiKone' offers an accessible learning experience tailored for busy families. It disseminates correct knowledge about dementia and emphasizes the importance of prevention and early detection. The YouTube channel features entertaining and comedic stories that involve slightly clumsy characters and their families, releasing educational videos approximately once a week.

These videos aim to convey knowledge about dementia in a fun and relatable manner. In addition to the videos, families that register for the official LINE account can enjoy several benefits for free:

- Sample LINE messages to check on the health of their elderly family members.
- A '1-minute family check' that helps recognize subtle changes in their loved ones' behavior.

Here are the links to engage with the program:

Context of the Initiative

According to estimates from the Ministry of Health, Labor and Welfare, by 2025, one in five elderly individuals aged 65 and above is expected to be diagnosed with dementia. Amid this concerning statistic, there is a rising focus on innovative treatment approaches that target the progression of conditions such as Alzheimer's disease. Global clinical trials for candidate drugs are accelerating, and the advancement of biomarkers and early diagnosis methods is on the rise.

In this context, understanding scientific and clinical trends has become crucial not only for patients but also for their families. Beyond treatment after onset, preventive efforts and early detection are paramount in dementia care. Hence, it is essential for families to cultivate an environment that fosters awareness and prompts them to notice crucial changes in daily life.

EPNextS, which has historically focused on supporting drug development, aims to proactively address preventive healthcare measures in an aging society. By extending healthy life expectancy, EPNextS seeks to contribute to resolving social challenges and advancing the health industry.

Expert Commentary

Dr. Yoshiyama Youmasashi, the director of Inage Neurology and Memory Clinic, emphasizes the importance of early preventive practices regarding dementia:
"Research has shown that changes in the brain related to dementia begin several years before diagnosis. These changes can be difficult to detect in daily life, and often families realize the problem only when it has progressed significantly. Therefore, adopting preventive daily habits early and encouraging families to observe small changes is critical. The 'FamiKone' initiative thoughtfully addresses both prevention and early discovery through entertaining videos, fostering more family conversations and actionable awareness surrounding dementia. I hope to see this type of community engagement grow, empowering society to better face dementia challenges."

Future Prospects

Through 'FamiKone,' EPNextS aims to widely share accurate information about dementia and encourage behavioral changes using digital media. The goal is for families to recognize the early signs of dementia and initiate proper consultations and actions. EPNextS commits to delivering easy-to-understand and engaging content continuously, enriching the options available to individuals and their families.

Furthermore, EPNextS plans to strengthen collaborations with research institutions, pharmaceutical and medical device manufacturers, and more to provide comprehensive support from clinical development to market introduction, seeking to lead the development and dissemination of medical products and devices in the dementia sector. Looking forward, collaboration across diverse fields such as insurance, finance, technology, and community services will promote the establishment of innovative systems utilized in daily life.

About EPNextS

EPNextS serves as a healthcare solution provider overseeing essential business divisions within the EPS Group, including clinical trial and post-marketing services. Established in 1991, the company comprises leading organizations in the CRO field such as EPS Corporation, EPLink, and EP Pharma Line, pooling approximately 7,000 professionals to deliver new business solutions in healthcare.